Fund Holdings — Palo Alto Investors LP

Total Portfolio Value:
$672.15M
Total Bought:
$66.35M
Total Sold:
$134.74M
Net Transaction:
-$68.39M
Notable People:
Palo Alto Investors Gp Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
PTC Therapeutics, Inc.(PTCT)918,846875,349-43,497$74.95M$56.71M8.44%-$18.25M
Iovance Biotherapeutics, Inc.(IOVA)5,296,2093,471,456-1,824,753$22.03M$51.45M7.65%+$29.41M
Insmed Incorporated(INSM)413,980443,645+29,665$44.14M$50.64M7.53%+$6.50M
Acadia Pharmaceuticals Inc2,864,0962,485,608-378,488$72.46M$50.09M7.45%-$22.38M
BioMarin Pharmaceutical Inc.(BMRN)682,777642,455-40,322$39.07M$38.55M5.73%-$521.2K
Mirum Pharmaceuticals, Inc.(MIRM)348,808387,314+38,506$40.83M$33.11M4.93%-$7.73M
United Therapeutics Corporation(UTHR)62,58758,875-3,712$33.91M$31.90M4.75%-$2.01M
Dyne Therapeutics, Inc.(DYN)1,647,5211,881,927+234,406$36.59M$30.32M4.51%-$6.27M
Biogen Inc.(BIIB)140,279132,918-7,361$30.31M$30.02M4.47%-$285.2K
Anaptysbio Inc603,489595,264-8,225$40.74M$29.92M4.45%-$10.82M
CareDx, Inc.(CDNA)531,870424,601-107,269$15.16M$27.60M4.11%+$12.44M
First Tracks Biotherapeutics603,489741,097+137,608$12.14M$26.26M3.91%+$14.12M
Disc Medicine, Inc.(IRON)416,646396,529-20,117$30.47M$25.96M3.86%-$4.52M
NovoCure Limited(NVCR)1,280,4391,209,774-70,665$19.40M$19.30M2.87%-$102.8K
Bicara Therapeutics Inc550,408689,344+138,936$16.34M$12.83M1.91%-$3.51M
Annexon Inc2,948,0902,811,222-136,868$16.83M$11.89M1.77%-$4.94M
Syndax Pharmaceuticals, Inc.(SNDX)864,986596,356-268,630$18.91M$11.21M1.67%-$7.70M
Celldex Therapeutics, Inc.(CLDX)399,856343,101-56,755$14.88M$11.12M1.65%-$3.76M
Ultragenyx Pharmaceutical Inc.(RARE)596,495710,029+113,534$19.92M$10.67M1.59%-$9.25M
Prothena Corp PlcSHS
SHS
1,143,1551,129,363-13,792$11.19M$9.46M1.41%-$1.73M
Travere Therapeutics, Inc.(TVTX)167,525158,946-8,579$9.52M$9.36M1.39%-$158.4K
Alkermes plcSHS(ALKS)242,560203,680-38,880$12.71M$8.25M1.23%-$4.46M
Compass Therapeutics Inc5,831,8137,148,673+1,316,860$12.77M$7.43M1.11%-$5.34M
Agios Pharmaceuticals, Inc.(AGIO)213,601200,984-12,617$7.93M$6.68M0.99%-$1.24M
Taysha Gene Therapies, Inc.(TSHA)1,391,3821,337,217-54,165$9.48M$6.51M0.97%-$2.96M
Aclaris Therapeutics Inc1,613,4301,156,396-457,034$8.54M$6.08M0.90%-$2.45M
Capricor Therapeutics Inc229,763548,071+318,308$5.53M$5.19M0.77%-$342.5K
Align Technology Inc31,38931,3890$5.29M$4.56M0.68%-$731.7K
Newamsterdam Pharma Company
ORDINARY SHARES
44,359162,874+118,515$1.50M$3.96M0.59%+$2.46M
Protara Therapeutics Inc01,035,964+1,035,964$0$3.16M0.47%+$3.16M
Contineum Therapeutics IncCL A0220,226+220,226$0$2.96M0.44%+$2.96M
Edwards Lifesciences Corp33,64033,6400$3.04M$2.90M0.43%-$139.3K
Verastem, Inc.(VSTM)309,685325,480+15,795$1.18M$2.62M0.39%+$1.44M
Neurocrine Biosciences, Inc.(NBIX)18,11718,1170$3.05M$2.57M0.38%-$483.6K
Sagimet Biosciences IncCOM SER A250,000250,0000$1.93M$2.47M0.37%+$537.5K
Adlai Nortye Group LtdADS0149,490+149,490$0$2.39M0.36%+$2.39M
Stoke Therapeutics, Inc.(STOK)84,63184,6310$2.77M$2.20M0.33%-$568.7K
Oruka Therapeutics, Inc.(ORKA)33,54625,563-7,983$3.19M$2.13M0.32%-$1.06M
CRISPR Therapeutics AGNAMEN AKT(CRSP)39,60536,949-2,656$2.16M$2.04M0.30%-$116.0K
Pyxis Oncology Inc864,277864,2770$2.60M$2.01M0.30%-$587.7K
Cytokinetics, Incorporated(CYTK)32,19530,036-2,159$2.74M$1.98M0.29%-$763.0K
BioNTech SEADS(BNTX)19,61419,6140$1.83M$1.93M0.29%+$103.0K
Nuvation Bio Inc.CL A(NUVB)326,609326,6090$1.86M$1.83M0.27%-$26.1K
Xenon Pharmaceuticals Inc.(XENE)51,34547,902-3,443$3.10M$1.78M0.27%-$1.32M
Humana Inc.(HUM)3,9853,9850$1.58M$1.52M0.23%-$62.4K
COMPASS Pathways plcADS(CMPS)115,616115,6160$1.64M$1.44M0.21%-$197.7K
Ehealth Inc1,482,7971,431,535-51,262$2.21M$1.02M0.15%-$1.19M
Xeris Biopharma Holdings Inc104,410104,4100$826.9K$998.2K0.15%+$171.2K
UroGen Pharma Ltd.(URGN)24,50024,5000$901.6K$995.4K0.15%+$93.8K
Madrigal Pharmaceuticals, Inc.(MDGL)1,7871,7870$959.5K$900.6K0.13%-$59.0K
Cybin Inc072,634+72,634$0$892.7K0.13%+$892.7K
Bicycle Therapeutics PlcADS201,890188,351-13,539$856.0K$693.1K0.10%-$162.9K
Inspire Medical Systems, Inc.(INSP)8,7728,7720$391.3K$608.4K0.09%+$217.1K
Abeona Therapeutics Inc108,865108,8650$672.8K$571.5K0.09%-$101.2K
Proqr Thrapeutics N VSHS EURO
SHS EURO
188,807188,8070$351.2K$313.4K0.05%-$37.8K
Aldeyra Therapeutics Inc155,709155,7090$331.7K$191.5K0.03%-$140.1K
Page 1 of 1
Palo Alto Investors LP — 13F Holdings — Q3 2026 | TickerTrail